IL17A and colitis: Furthermore, FRB was able to mitigate the mRNA level of Il-17 (p = 0.003 at 2 weeks and p < 0.001 at 5 weeks, Figure 5B), a cytokine which is commonly produced by T helper (Th17) cells and plays the role of an important mediator in the pathogenesis of colitis [43,44].